Biome Australia Limited Half Year Report
Biome Australia Limited Appendix 4D Half-year report
Biome Australia Limited
Biome Releases First Half FY2024 Results ● Biome reports record half year and quarterly sales revenue (H1FY24 $6.02m; Q2FY24 $3.3m)… Read more
Biome Australia – Quarterly Activities & Appendix 4C December 2023
Highlights ● Biome reports record $3.3m sales revenue and $3.07m cash receipts in Q2 FY24 ● Biome records first… Read more
Biome Australia Limited (ASX : BIO)
Biome to launch into UK and Ireland health retail markets ● Launch of Biome’s Activated Probiotics into key European health… Read more
Biome Australia – FY24 Revenue Guidance Upgrade to $12.5M
On Monday this week, Biome Australia Limited (ASX: BIO) announced an upgrade to their FY2024 revenue forecast from $11.5m to… Read more
Biome Achieves Record Quarter and Half Year Sales Revenue
Happy New Year from Canary Capital. Biome Australia has this morning announced record sales revenue for both the December quarter… Read more
Biome to launch cholesterol reducing probiotic
What an incredible year it has been for Biome Australia Limited (ASX: BIO). Biome Activated Probiotics is now the fastest growing… Read more
Biome Australia Ltd Signs Landmark Agreement
Biome Australia Limited (ASX:BIO) announced this morning that they have signed a landmark agreement with one of its key probiotic… Read more
Biome Australia – Results of Annual General Meeting
Microbiome health company, Biome Australia Limited (ASX:BIO, “Biome” or “the Company”), announces in accordance with Listing Rule 3.13.2 and Section… Read more